Two patients (numbers 10 and 12) were classified as “probable DISR” despite concurrent melanoma metastases, based on the typical radiological presentation, elevated sIL2R/ACE levels, and/or regression of symptoms and lesions under systemic steroid therapy. This evidence concerns the gene ACE and melanoma.